Computer Aided Screening for Tuberculosis in Low Resource Environments
Conditions:   Tuberculosis Infection;   HIV Infections Interventions:   Diagnostic Test: CAD4TB;   Diagnostic Test: FujiLAM Sponsors:   London School of Hygiene and Tropical Medicine;   Liverpool School of Tropical Medicine;   University of Malawi College of Medicine;   Malawi-Liverpool-Wellcome Trust Clinical Research Programme Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2020 Category: Research Source Type: clinical trials

Computer Aided Screening for Tuberculosis in Low Resource Environments
Conditions:   Tuberculosis Infection;   HIV Infections Interventions:   Diagnostic Test: CAD4TB;   Diagnostic Test: FujiLAM Sponsors:   London School of Hygiene and Tropical Medicine;   Liverpool School of Tropical Medicine;   University of Malawi College of Medicine;   Malawi-Liverpool-Wellcome Trust Clinical Research Programme Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital);   Beijing Kangterike Statistical Technology Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions:   Infertility, Female;   Recurrent Implantation Failure;   Genital Tuberculoses, Female;   Genital Tuberculosis, Latent Intervention:   Drug: rifapentine plus isoniazid Sponsors:   Huashan Hospital;   Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials

GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment
Condition:   Latent Tuberculosis Interventions:   Other: Strategy 2: Symptom screen, Genexpert and TST;   Other: Strategy 3:Symptom screen, CXR but NO TST Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials